Login to Your Account

Canbridge moves ahead with $10M in mezzanine financing

By Shannon Ellis
Staff Writer

Monday, October 26, 2015
SHANGHAI – Beijing-based Canbridge Life Science Inc., a biotech focused on developing Western drugs that treat China-specific diseases, has received an additional $10 million in VC financing, doubling the round it completed last year and putting the total venture financing at $20 million.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription